
Ctmor S 250mg/125mg Injection
Marketer
Aamorb Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ctmor S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections. This medication inhibits microbial proliferation, halting infection spread. Administration must be under a physician's guidance; strictly adhere to the prescribed schedule. Complete the full course, even with symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your doctor. Seek urgent medical attention for allergic reactions (skin rashes, itching, edema, respiratory distress). Inform your doctor of all current medications, especially if you are pregnant, breastfeeding, or have pre-existing conditions. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if experiencing dizziness or sleepiness. Adequate rest, a nutritious diet, and hydration are crucial for optimal recovery. Your doctor may order tests to monitor the treatment's effects.
Uses of Ctmor S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ctmor S 250mg/125mg Injection:
The medication will be administered by your physician or their assistant; self-medication is strongly discouraged.
Common Side effects of Ctmor S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ctmor S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ctmor S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam 250mg/125mg Injection (Ctmor S) combines a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Sulbactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Ctmor S 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ctmor S, 250mg/125mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
The administration of Ctmor S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Ctmor S 250mg/125mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Operation of a motor vehicle should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ctmor S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The injectable medication Ctmor S (250mg/125mg) requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Medical advice should be sought. Dosage changes for Ctmor S (250mg/125mg) Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ctmor S 250mg/125mg Injection :
Omit a Ctmor S 250mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Ctmor S 250mg/125mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Agents against infection |
